GX LL7 Pill - pink capsule/oblong, 21mm
Generic Name: fosamprenavir
Pill with imprint GX LL7 is Pink, Capsule/Oblong and has been identified as Lexiva 700 mg. It is supplied by GlaxoSmithKline.
Lexiva is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Lexiva 700 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX LL7
Lexiva
- Generic Name
- fosamprenavir
- Imprint
- GX LL7
- Strength
- 700 mg
- Color
- Pink
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0721 (Discontinued)
More about Lexiva (fosamprenavir)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: protease inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.